Skip to main content

Vanderbilt Eye Institute Archives

Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Jun. 25, 2015—Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

Read more


VEI receives grant from Research to Prevent Blindness for research and education

Jun. 25, 2015—The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.

Read more


Beware the eyes of March: Vanderbilt ophthalmologist offers tips for preventing and treating dry eyes during windy weather

Mar. 23, 2015—For the past few months, much of the nation has donned hats, boots, scarves and gloves as they face brutally cold and icy conditions of winter. As temperatures rise, making outdoor activities more enticing, Vanderbilt ophthalmologists suggest not to be in such a hurry to stop protecting yourself from the elements. Why? March is known...

Read more


VUMC’s Penn named president-elect of eye research society

Feb. 12, 2015—John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER).

Read more


Retinal neuron survival in glaucoma

Dec. 16, 2014—Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.

Read more


Project PAVE’s impact on children’s vision easy to see

Oct. 16, 2014—It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.

Read more


Novel therapy eases stress of retinoblastoma treatment

Oct. 9, 2014—Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.

Read more


Biomarker for diabetic eye disease

Sep. 26, 2014—A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.

Read more


Keeping an eye on blast trauma

Aug. 19, 2014—Understanding the cellular and molecular responses of the eye to blast injury could guide new treatment development.

Read more


Award highlights Wayman’s resident education efforts

Aug. 14, 2014—Laura Wayman, M.D., associate professor of Ophthalmology and Visual Sciences, has been awarded the 2014 Straatsma Award for Excellence in Resident Education.

Read more


VEI taking novel approach to fight blinding diseases

Aug. 14, 2014—Personalized medicine — the effort to tailor health care to individual patients’ needs, genetic profiles and circumstances — is a well-established concept at Vanderbilt University Medical Center.

Read more


Agarwal’s macular diseases research lands high honor

Apr. 3, 2014—Walk into ophthalmologist Anita Agarwal’s office at the Vanderbilt Eye Institute and there is something remarkably different about the décor.

Read more


Recent Stories from VUMC News and Communications Publications

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

Vanderbilt Medicine

Keeping pace: Nashville, once a mid-size city with a Southern small-town feel, is experiencing explosive growth.

VUMC campus

VUMC campus

Vanderbilt University School of Medicine entrance

Vanderbilt University School of Medicine entrance

Vanderbilt University Adult Hospital with helipad

Vanderbilt University Adult Hospital with helipad

more